Wai Chun Bio-Technology Limited (HKG:0660)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.670
-0.030 (-4.29%)
Apr 29, 2026, 3:54 PM HKT
679.07%
Market Cap 124.93M
Revenue (ttm) 568.26M
Net Income (ttm) -6.90M
Shares Out 178.48M
EPS (ttm) -0.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 264,000
Average Volume 4,091,800
Open 0.650
Previous Close 0.700
Day's Range 0.650 - 0.710
52-Week Range 0.086 - 2.330
Beta 0.47
RSI 49.94
Earnings Date Feb 27, 2026

About Wai Chun Bio-Technology

Wai Chun Bio-Technology Limited, an investment holding company, engages in the manufacture and sale of modified starch and other biochemical products in the People’s Republic of China. The company was formerly known as Wai Chun Mining Industry Group Company Limited and changed its name to Wai Chun Bio-Technology Limited in September 2019. The company was incorporated in 1992 and is headquartered in Wan Chai, Hong Kong. [Read more]

Industry Chemicals
Sector Materials
Founded 1992
Employees 63
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 0660
Full Company Profile

Financial Performance

In fiscal year 2025, Wai Chun Bio-Technology's revenue was 377.17 million, an increase of 1.92% compared to the previous year's 370.07 million. Losses were -14.62 million, -66.93% less than in 2024.

Financial Statements

News

There is no news available yet.